Ann Clin Microbiol.  2021 Dec;24(4):127-134. 10.5145/ACM.2021.24.4.3.

emm Types and Clusters of Group A Streptococcus Causing Acute Pharyngitis in Changwon Korea, 2018–2019

• Jo SA
• Lee S
• Kim S

• KMID: 2523569
• DOI: http://doi.org/10.5145/ACM.2021.24.4.3

Abstract

Background
Group A streptococcus (GAS) is the most common cause of bacterial pharyngitis. This study aimed to characterize the molecular epidemiology of GAS infection using an emm-typing and emm-clustering approach.
Methods
A total of 372 patients from Changwon who showed pharyngitis symptoms were recruited during the sampling period of 2018–2019 and throat cultures were obtained from them. emm typing was performed using polymerase chain reaction (PCR) and direct sequencing. emm genotypes and GAS clusters were classified based on a web-based database.
Results
Of the 372 throat swab specimens, 101 (27.2%) were positive for GAS. emm typing analysis was performed on 59 GAS isolates. The most prevalent emm type was emm89 (20.3%), followed by emm12 (16.9%). Seven emm clusters were identified: E4 (emm89/ emm28, 32.2%), A-C4 (emm12, 16.9%), E1 (emm4, 13.6%), A-C5 (emm3, 10.2%), E6 (emm75, 8.5%), M6 (emm6, 8.5%), and A-C3 (emm1, 6.8%).
Conclusion
Diverse and temporal changes were observed in the distribution of emm types and clusters of GAS. Continuous surveillance based on emm genotyping is needed to monitor the epidemiological characteristics of GAS pharyngitis.

Keyword

Epidemiological surveillance; Group A streptococcus; Streptococcus pyogenes; Pharyngitis

Reference

1. Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjanen J. Predictors of mortality in betahemolytic streptococcal bacteremia: a population-based study. J Infect 2009;58:266-72. .

2. Steer AC, Jenney A, Kado J, Good MF, Batzloff M, Waqatakirewa L, et al. Prospective surveillance of invasive group a streptococcal disease, Fiji, 2005-2007. Emerg Infect Dis 2009;15:216-22. .

3. Safar A, Lennon D, Stewart J, Trenholme A, Drinkovic D, Peat B, et al. Invasive group A streptococcal infection and vaccine implications, Auckland, New Zealand. Emerg Infect Dis 2011;17:983-9. .

4. Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005;5:685-94. .

5. Walker MJ, Barnett TC, McArthur JD, Cole JN, Gillen CM, Henningham A, et al. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev 2014;27:264-301. .

6. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128. .

7. Fischetti VA. Vaccine approaches to protect against aroup A streptococcal pharyngitis. Microbiol Spectr 2019;7:3. .

8. Baroux N, D'Ortenzio E, Amedeo N, Baker C, Ali Alsuwayyid B, Dupont-Rouzeyrol M, et al. The emm-cluster typing system for group A Streptococcus identifies epidemiologic similarities across the Pacific region. Clin Infect Dis 2014;59:e84-92. .

9. Gherardi G, Vitali LA, Creti R. Prevalent emm types among invasive GAS in Europe and North America since year 2000. Front Public Health 2018;6:59. .

10. McMillan DJ, Sanderson-Smith ML, Smeesters PR, Sriprakash KS. Molecular markers for the study of streptococcal epidemiology. In: Chhatwal G, ed. Host-pathogen interactions in streptococcal diseases. Current topics in microbiology and immunology. Berlin; Springer, 2012:29-48. .

11. Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis 2003;3:191-200. .

12. Smeesters PR, McMillan DJ, Sriprakash KS. The streptococcal M protein: a highly versatile molecule. Trends Microbiol 2010;18:275-82. .

13. Beall B, Facklam R, Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996;34:953-8. .

14. Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, et al. emm typing and validation of provisional M types for group A streptococci. Emerg Infect Dis 1999;5:247-53. .

15. Lamagni TL, Efstratiou A, Vuopio-Varkila J, Jasir A, Schalen C, Strep E. The epidemiology of severe Streptococcus pyogenes associated disease in Europe. Euro Surveill 2005;10:179-84.

16. O'Loughlin RE, Roberson A, Cieslak PR, Lynfield R, Gershman K, Craig A, et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007;45:853-62. .

17. Steer AC, Law I, Matatolu L, Beall BW, Carapetis JR. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 2009;9:611-6. .

18. Sanderson-Smith M, De Oliveira DM, Guglielmini J, McMillan DJ, Vu T, Holien JK, et al. A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. J Infect Dis 2014;210:1325-38. .

19. Imperi M, Pittiglio V, D'Avenio G, Gherardi G, Ciammaruconi A, Lista F, et al. A new genotyping scheme based on MLVA for inter-laboratory surveillance of Streptococcus pyogenes. J Microbiol Methods 2016;127:176-81. .

20. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing, 25th informational supplement. M100–S25. Wayne; PA, 2015. .

21. Kim SW, Lee SJ, Park HW, Kim SJ. Predominance of emm4 and antibiotic resistance of Streptococcus pyogenes in acute pharyngitis in a southern region of Korea. J Med Microbiol 2019;68:1053-58. .

22. Choi JH, Yang NR, Lee JW, Lee HJ, Choi EH, Lee HJ. Distribution of emm types among group A Streptococcus isolates from children in Korea. Diagn Microbiol Infect Dis 2015;82:26-31. .

23. Kim HH, Oun JS, Yoo JI, Hwang HK. Genetic distribution of Streptococcus pyogenes isolated through a surveillance system to assess respiratory infection pathogens in Korea. Division of Bacterial Diseases, Center for Laboratory Control of Infectious Disease, KCDC 2007-2018. https://www.kdca.go.kr/upload_comm/syview/doc.html?fn=157415864054300.pdf&rs=/ upload_comm/docu/0031/ [Online] (last visited on 24 November 2021). .

24. Park DW, Kim SH, Park JW, Kim MJ, Cho SJ, Park HJ, et al. Incidence and characteristics of scarlet fever, South Korea, 2008-2015. Emerg Infect Dis 2017;23:658-61. .

25. Liu YM, Zhao JZ, Li BB, Yang JY, Dong XG, Zhang JJ, et al. A report on the first outbreak of a single clone group A Streptococcus (emm-type 89) tonsillopharyngitis in China. J Microbiol Immunol Infect 2014;47:542-5. .

26. Tamayo E, Montes M, Garcia-Arenzana JM, Perez-Trallero E. Streptococcus pyogenes emmtypes in northern Spain; population dynamics over a 7-year period. J Infect 2014;68:50-7. .

27. Dale JB, Smeesters PR, Courtney HS, Penfound TA, Hohn CM, Smith JC, et al. Structurebased design of broadly protective group a streptococcal M protein-based vaccines. Vaccine 2017;35:19-26.